This site is intended for heath plan professionals in Canada.
This site is intended for health plan professionals in Canada.
U.S. professionals should visit ManagedCareCGM.com
This site is intended for health plan professionals in Canada.
U.S. professionals should visit ManagedCareCGM.com
2025 ADA Standards of Care Highlight Consensus Support for Broader Application of CGM – ManagedCareCGM.com – January 16, 2025
Real-World Managed Care Data Show Reduction in HbA1c and Diabetes-Related Resource Utilization Associated with CGM Regardless of Insulin Treatment – Journal of Managed Care Pharmacy – November 16, 2024
AMCP Market Insights Health Plan Best Practices: Implementing Continuous Glucose Monitoring to Improve Patient Outcomes in Diabetes- Journal of Managed Care and Specialty Pharmacy– January 8, 2024
Payer and Health System Experts Share Insights on the Role of CGM in Population Health Management– American Journal of Accountable Care via ManagedCareCGM.com- December 6, 2023
ADA 2023 Highlights: The Clinical and Economic Value of CGM – ManagedCareCGM.com – September 15, 2023
Latest Research in Diabetes Technology: Highlights from ATTD 2022 – ManagedCareCGM.com – July, 2022
ADA Standards of Medical Care: Recommendations for Continuous Glucose Monitoring – A Video Resource – ManagedCareCGM.com – May, 2022
The Value of rtCGM in Optimizing the Management of T2D – A Video Resource – ManagedCareCGM.com – January 2022
Lower A1c and Reduce Hospital/ED Use in Members with Insulin-Treated Type 2 Diabetes via Real-Time Continuous Glucose Monitoring – ManagedCareCGM.com – September 2021
FDA gives the go ahead for third-party developers to integrate real-time CGM data into their digital health apps and devices. – Business Wire – July 2021
This website is supported by an educational grant from Dexcom, Inc.
